Archive for July, 2009
Applying cognitive neuropsychological principles to the rehabilitation of spanish readers with acquired dyslexia.
Authors: Cuetos F, Centeno JG
Cognitive neuropsychological models (CNMs) have been useful to generate a theory of aphasia rehabilitation. In contrast to the traditional syndrome approach, CNMs employ cognitive accounts to interpret language disturbances after brain damage. In this article, we apply CNMs to monolingual Spanish and bilingual Spanish-English readers with acquired dyslexia whose first language is Spanish. Although there are many studies of acquired dyslexia (reading errors associated with aphasia), they primarily have focused on English and French readers. Similar investigations on Spanish readers are limited. Unlike the opaque orthographic systems of English and French (inconsistent grapheme-to-phoneme relationships), Span…
Saxagliptin Approval: Finally, Competition for Merck’s Januvia
The FDA just approved saxagliptin, a diabetes medicine that will be co-marketed by Bristol-Myers Squibb and AstraZeneca. The drug, which will be sold under the brand name Onglyza, is in a relatively new class, called DPP-4 inhibitors, that can be taken along with older diabetes drugs.
Until now, Merck#8217;s Januvia has been the only drug in the class on the market in this country. But in late 2006, when Januvia was approved by the FDA, you wouldn#8217;t have guessed that Merck would have the market to itself for so long. That it has is a sign of the tough safety scrutiny the FDA has given to many new drugs in recent years.
The 2006 WSJ story on Januvia#8217;s approval noted that Galvus, a DPP-4 drug from Novartis, was also awaiting approv…
My view on low carb diets? It’s complicated.
Q.#0160;#0160;#0160;#0160;From reading your blog it seems that a lot of your readers back low carb diets.#0160; Being a student studying nutrition, everything I have read has said that a low carb diet is terrible for your health.#0160; Can you address your views on this in your blog?
A.#0160;#0160;#0160;It#39;s something that comes up a lot on the blog and always seems to elicit very strong opinions.#0160; Several regular commenters are quite ardent about the evils of carbohydrates.#0160;#0160;My views are somewhat more moderate.#0160; I do think that refined carbohydrates are a big part of the problem with the Western diet.#0160; I think that overconsumption of refined carbohydrates (especially in the context of a sedentary lifestyle) cont…
Type 2 Diabetes Raises the Risk of Parkinsons Disease
A shocking discovery is just coming out linking Type 2 Diabetes to Parkinson#8217;s Disease. There are nearly 1.5 million Americans diagnosed with Parkinson#8217;s Disease, according to the National Parkinsons Foundation, which is a disease affecting brain cells and neurons causing reduced levels of dopamine. The lowered levels of dopamine cause such side effects as tremors, paralysis and death.
#8220;Scottie#8221; also suffered from Type 2 diabetes and Parkinson#8217;s disease during Star Trek
Overall, after adjusting for other possible risk factors for Parkinson#8217;s disease, men and women with type 2 diabetes were 83 percent more likely to develop Parkinson#8217;s disease than those without it.
Although common lifestyle factors may …
What a New Era of Pharma Marketing Means to (Diabetes) Patients
As you may have noticed, I#8217;m fascinated with where new Web-enabled communication tools are taking us in the world of medicine in healthcare. I#8217;m also a huge admirer of the work of the outspoken and sage John Mack, publisher of Pharma Marketing News and author of the Pharma Marketing Blog. I was therefore delighted when […] (Source: Diabetes Mine)Original post by Diabetes Mine
No commentsWhat Rorschach Tests Really Tell Us
One of the most well-known psychological tools is the Rorschach Inkblot Test. A viewer looks at ten inkblots, one at a time, and describes what they see. The rationale behind this test is the idea that certain aspects of the subject’s personality will be exposed as they are interpreting the images, allowing for the possible diagnosis of various psychological disorders.Original post by Allergy News From Medical News Today
No commentsHouse Democrats Set To Move Bill After Accord With Blue Dogs, Liberals Objecting
House Democrats on Wednesday made a deal with fiscally conservative Blue Dog Democrats on a health reform bill that “would reduce the overall cost of the package and ensure more funding for rural hospitals, concessions that could allow the Energy and Commerce Committee to finish its consideration of the legislation,” The Washington Post reports.Original post by Diabetes Mine
No commentsPolls Find Public Support For Health Overhaul Losing Steam
Two new polls show support for President Barack Obama’s health care efforts slipping over the past month. Over the past five weeks, support has declined “particularly among those who already have insurance, a Wall Street Journal/NBC News poll found, amid prolonged debate over costs and quality of care,” The Wall Street Journal reports.Original post by Diabetes Mine
No commentsLobbyists Continue Pressing Their Cases
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed. “One of the groups key to working any deal is the pharmaceutical industry, which has been quite active behind the scenes,” National Public Radio reports.Original post by Diabetes Mine
No commentsRecession-Battered States Cut Funding For Health Services
Under economic pressure, states are slashing funding for health services from Connecticut to California. The cuts frustrate providers and lawmakers are looking for ways to limit harm. The Original post by Diabetes Mine
No comments